Investigative Site — Clearwater, Florida

Public research footprint of Investigative Site, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Systemic Lupus Erythematosus · Primary Prevention of Atherosclerotic Cardiovascular Disease · Wet Age-related Macular Degeneration · Cutaneous Lupus Erythematosus (CLE)

Recently updated registry entries

NCT05739383 — A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention… (Active Not Recruiting)
NCT07260877 — A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an… (Recruiting)
NCT05639114 — Phase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-of-care Therapy in… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Investigative Site?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.